Dupilumab treatment led to significant SCORAD score reductions, with 37% achieving a 75% reduction and 72% reaching mild disease status by week 16. Improvements were observed as early as week 2, with ...
Web-based stress management for newly diagnosed cancer patients (STREAM): A randomized, wait-list controlled intervention study. Adverse health outcomes in relationship to hypogonadism (HG) after ...
NEW YORK CITY -- An oral drug that targets Th2 activity in atopic dermatitis reduced disease activity by as much as 50% after 6 weeks, results of a small placebo-controlled study showed. At 4 weeks of ...
Lorazepam as an adjuvant to haloperidol for agitated delirium at the end of life: A double-blind randomized controlled trial. Effect of inpatient palliative care during hematopoietic stem cell ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results